Teleflex (TFX) Net Income towards Common Stockholders (2009 - 2026)
Teleflex (TFX) posted Net Income towards Common Stockholders of -$3.3 million for Q1 2026, up 99.53% on a QoQ basis from -$710.8 million in Q4 2025, and down 107.77% year-over-year from $42.7 million in Q1 2025.
Teleflex (TFX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Teleflex's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at -$3.3 million for Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 107.77% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 billion (down 29103.64% YoY) and the FY2025 annual result came in at -$1.1 billion, down 8888.64% from the prior year.
- Net Income towards Common Stockholders was -$3.3 million for Q1 2026 at Teleflex, up from -$710.8 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $248.5 million in Q4 2023 and bottomed at -$710.8 million in Q4 2025.
- A 5-year average of -$41.6 million and a median of -$41000.0 in 2022 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders slumped 22500.0% — and 2024, when it surged 66940.91%.
- Teleflex's Net Income towards Common Stockholders stood at $552000.0 in 2022, then jumped by 44922.83% to $248.5 million in 2023, then plunged by 169.43% to -$172.5 million in 2024, then sank by 311.93% to -$710.8 million in 2025, then jumped by 99.53% to -$3.3 million in 2026.
- Business Quant data shows TFX's Net Income towards Common Stockholders at -$3.3 million in Q1 2026, -$710.8 million in Q4 2025, and -$350.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Teleflex | 5.81 Bn | 5.50 Bn | 307.43 Mn | -3.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.32 Mn |
| Dec 31, 2025 | -710.78 Mn |
| Sep 28, 2025 | -350.47 Mn |
| Jun 29, 2025 | 54.41 Mn |
| Mar 30, 2025 | 42.67 Mn |
| Dec 31, 2024 | -172.55 Mn |
| Sep 29, 2024 | 67.60 Mn |
| Jun 30, 2024 | 58.82 Mn |
| Mar 31, 2024 | 58.61 Mn |
| Dec 31, 2023 | 248.53 Mn |
| Oct 1, 2023 | -687,000.00 |
| Jul 2, 2023 | -88,000.00 |
| Apr 2, 2023 | -711,000.00 |
| Dec 31, 2022 | 552,000.00 |
| Sep 25, 2022 | 19,000.00 |
| Jun 26, 2022 | -41,000.00 |
| Mar 27, 2022 | -226,000.00 |
| Dec 31, 2021 | 692,000.00 |
| Sep 26, 2021 | -423,000.00 |
| Jun 27, 2021 | -35,000.00 |